Dr. David Ollila, MD is a board certified general surgeon in Chapel Hill, North Carolina. He is currently licensed to practice medicine in North Carolina. He is affiliated with University of North Carolina Hospitals, Rex Healthcare, and WakeMed Health and Hospitals.
Clinical Specialties & Interests
General Surgery: Surgical Oncology (Other than Breast)
Education & Medical Training
Riverside Methodist Hospitals/OhioHealth University of Cincinnati College of Medicine
Certifications & Licensure
NC State Medical License 1998 - 2015 American Board of SurgerySurgery
Awards, Honors, & Recognition
Meaningful Use Stage 1 CertificationCenters for Medicare & Medicaid Services, 2012 Fellow (FACS)American College of Surgeons
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer Start of enrollment: 2012 Jul 01 Hollingsworth, A.,Lyss, A.,Lyss, A.P.,Lyss, A.P.,DeNittis, A.,Jaslowski, A.J.,Demestihas, A.,Giuliano, A.,Bass, B.,Marchello, B.T.,Ridgeway, C.,Tiber, C.H.,Tiber, C.,Kubicky, C.,Dodge, D.G.,Nikcevich, D.A... Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery Start of enrollment: 2002 May 01 Ollila, D.W.
Publications & Presentations
PubMed Another Brick in the Wall: Toward a Better Understanding of Melanoma of Unknown Primary. Ollila, D. W.,Meyers, M. O.; Ann. Surg. Oncol.. 2014 Sep 10. Comparison of Clinicopathologic Features and Survival of Histopathologically Amelanotic and Pigmented Melanomas: A Population-Based Study. Thomas, N. E.,Kricker, A.,Waxweiler, W. T.,Dillon, P. M.,Busam, K. J.,From, L.,Groben, P. A.,Armstrong, B. K.,Anton-Culver, H.,Gruber, S. B.,Marrett, L. D.,Gallagher, ...; JAMA Dermatol. 2014 Aug 28. DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features. Thomas, N. E.,Slater, N. A.,Edmiston, S. N.,Zhou, X.,Kuan, P. F.,Groben, P. A.,Carson, C. C.,Hao, H.,Parrish, E.,Moschos, S. J.,Berwick, M.,Ollila, D. W.,Conway, K.; Pigment Cell Melanoma Res. 2014 Jul 06. Register to See 75 More
Immunotherapy With A Polyvalent Melanoma Vaccine PLUS BCG In Stage IVNational Center For Research Resources 2004 - 2006 Active Immunotherapy With A Polyvalent Melanoma Vaccine In Stage IIINational Center For Research Resources 2004 - 2006 Immunotherapy W/ Melanoma Vaccine PLUS BCG In MelanomaNational Center For Research Resources 2000 - 2000 Active Immunotherapy W/ BCG &Melanoma Vaccine, CancervaNational Center For Research Resources 2000 - 2000
Aetna Choice POS II Aetna HMO BCBS Blue Card PPO BCBS Idaho PPO BCBS North Carolina BlueOptions PPO CIGNA HMO CIGNA Open Access CIGNA PPO Empire BCBS HMO Empire BCBS PPO First Health PPO GHI PPO Great West PPO Healthfirst New York HIP of New York - Select PPO Humana ChoiceCare Network PPO MagnaCare PPO Multiplan PHCS PPO Multiplan PPO MVP Healthcare PPO Oxford Health Freedom Oxford Health Liberty PacificSource Preferred PSN United Healthcare - Direct Choice Plus POS United Healthcare - Direct Options PPO
Dr. David Ollila, Dr. David Ollila, MD, Dr. D Ollila, Dr. David W Ollila